Publication on transplant coordnators’ experiences of the impact of generic immunosuppressants on them and their patients. A key finding was increased patient confusion with associated increase in workload for the cooridnators.
A study on bioequivalence of Prograf and Tacni in elderly renal transplant recipients highlights differences in practice
A new study published in Pediatric Transplantation compared the bioavailability of Prograf and generic tacrolimus. It found reduced tacrolimus exposure with the generic formulation.
Letter published in the Pharmaceutical Journal which reinforces the importance of the 2012 MHRA guidance on tacrolimus and encourages effective implementation in the community.
Results of the MHRA’s latest review on appropriate prescribing and dispensing of tacrolimus – supercedes advice in 2009 Drug Safety Update
Should you have difficulty accessing these materials or require further information, please contact the ESPRIT Group Secretariat at email@example.com.